{"id":7374,"date":"2022-04-06T09:44:10","date_gmt":"2022-04-06T17:44:10","guid":{"rendered":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7374"},"modified":"2022-04-08T16:01:41","modified_gmt":"2022-04-09T00:01:41","slug":"fda-pulls-authorization-for-gsk-virs-covid-therapy-sotrovimab-as-ba-2-cases-rise","status":"publish","type":"post","link":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7374","title":{"rendered":"FDA Pulls Authorization for GSK-Vir&#8217;s COVID Therapy, Sotrovimab, as BA.2 Cases Rise"},"content":{"rendered":"<p><strong><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/fda-says-gsk-virs-sotrovimab-no-longer-authorized-treat-covid-us-2022-04-05\/\">The U.S. health regulator said on Tuesday GlaxoSmithKline (GSK.L) and Vir Biotechnology&#8217;s (VIR.O) antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant Omicron sub-variant in the country.<\/a><\/strong><\/p>\n<p>Drug Information for COVID-19 Monoclonal Antibody (Bebtelovimab) and COVID-19 Polyclonal Antibody Evusheld (Tixagevimab-Cilgavimab) Available on ApoThera Clinical Decision Support App<\/p>\n<p><strong><a href=\"https:\/\/apps.apple.com\/us\/app\/apothera\/id526613282\">Drug Info: <em>ApoThera Drug Disease Clinical Support App<\/em><\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. health regulator said on Tuesday GlaxoSmithKline (GSK.L) and Vir Biotechnology&#8217;s (VIR.O) antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to&hellip;<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[16],"tags":[298,264,301,297,268,270,266,299,302,303,300],"class_list":["post-7374","post","type-post","status-publish","format-standard","hentry","category-blog","tag-bebtelovimab","tag-biotech","tag-cilgavimab","tag-clinical-decision-support","tag-covid","tag-covid19","tag-drug-information","tag-evusheld","tag-gsk","tag-sotrovimab","tag-tixagevimab"],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":7530,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7530","url_meta":{"origin":7374,"position":0},"title":"Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and Evusheld (Tixagevimab-Cilgavimab)","date":"April 8, 2022","format":"image","excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Drug Info: ApoThera Drug Disease Clinical Support App Drug Information for COVID-19 Monoclonal Antibodies (Bebtelovimab) and COVID-19 Polyclonal Antibody Evusheld (Tixagevimab-Cilgavimab) Available on ApoThera Clinical Decision Support Mobile \u00a0","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2022\/04\/COVID.19.Viral_.Replication.and_.Symptom.Onset_.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":7321,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7321","url_meta":{"origin":7374,"position":1},"title":"COVID-19 PCR Test, COVID-19 Antigen Test and COVID-19 Antibody Test","date":"April 5, 2022","format":"image","excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"https:\/\/i0.wp.com\/store.apotheraspecialtypharmacy.com\/wp-content\/uploads\/2022\/04\/COVID.Antigen.Antibody.PCR_.Tests_.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":7324,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7324","url_meta":{"origin":7374,"position":2},"title":"Monoclonal Antibodies for Treating Severe Asthma","date":"April 5, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App ApoThera Specialty Medications, Monoclonal Antibodies, Available for Treating Severe Asthma: - Cinqair (Reslizumab) - Dupixent (Dupilumab) - Fasenra (Benralizumab) - Tezspire (Tezepelumab) \u00a0","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7301,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7301","url_meta":{"origin":7374,"position":3},"title":"Tezspire (Tezepelumab), Monoclonal Antibody for the Treatment of Severe Asthma","date":"April 5, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Severe Asthma - 210 mg SC every 4 weeks - Add-on maintenance treatment of severe asthma Missed Dose - Administer dose as soon as possible - Thereafter, resume dosing on the usual day of administration - If the next dose is already\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7537,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7537","url_meta":{"origin":7374,"position":4},"title":"Drug Info for Lagevrio (Molnupiravir), Oral Medication for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application","date":"April 9, 2022","format":false,"excerpt":"Drug Information for Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Paxlovid (Nirmatrelvir-Ritonavir) and Molnupiravir (Lagevrio), Available on ApoThera Clinical Decision Support Mobile Application Drug Info: ApoThera Drug Disease Clinical Support App Molnupiravir (Lagevrio) - 800 mg (four 200-mg capsules) by mouth every 12 hours x 5 days - Treatment\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":7542,"url":"https:\/\/store.apotheraspecialtypharmacy.com\/?p=7542","url_meta":{"origin":7374,"position":5},"title":"Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application","date":"April 9, 2022","format":false,"excerpt":"Drug Info: ApoThera Drug Disease Clinical Support App Nirmatrelvir-Ritonavir (Paxlovid) - 300 mg nirmatrelvir + 100 mg Ritonavir by mouth twice daily x 5 days - Initiate as soon as possible after COVID-19 diagnosis and within 5 days of symptom onset - Completing the full 5-day treatment course and isolate\u2026","rel":"","context":"In &quot;Blog&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7374"}],"version-history":[{"count":1,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7374\/revisions"}],"predecessor-version":[{"id":7375,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=\/wp\/v2\/posts\/7374\/revisions\/7375"}],"wp:attachment":[{"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/store.apotheraspecialtypharmacy.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}